Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Calcium Channel
    (27)
  • AChR
    (2)
  • AMPK
    (1)
  • Antibacterial
    (1)
  • Apoptosis
    (1)
  • COX
    (1)
  • Carbonic Anhydrase
    (1)
  • Endogenous Metabolite
    (1)
  • GABA Receptor
    (1)
  • Others
    (63)
Filter
Search Result
Results for "

t-type

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    125
    TargetMol | Inhibitors_Agonists
  • Compound Libraries
    1
    TargetMol | Compound_Libraries
  • Peptide Products
    14
    TargetMol | Peptide_Products
  • Inhibitory Antibodies
    4
    TargetMol | Inhibitory_Antibodies
  • PROTAC Products
    1
    TargetMol | PROTAC
  • Natural Products
    12
    TargetMol | Natural_Products
  • Recombinant Protein
    160
    TargetMol | Recombinant_Protein
  • Isotope Products
    3
    TargetMol | Isotope_Products
  • Antibody Products
    21
    TargetMol | Antibody_Products
  • Cell Research
    13
    TargetMol | Inhibitors_Agonists
Trimethadione
3,5,5,-Trimethyloxazolidine-2,4-dione
T0283127-48-0
Trimethadione (3,5,5-Trimethyloxazolidine-2,4-dione) is a dione-type anticonvulsant with antiepileptic activity.
  • $47
In Stock
Size
QTY
t-type calcium channel inhibitor 2
T64203
T-Type calcium channel inhibitor 2 (compound 6g) is a potent inhibitor of the T-type calcium channel, specifically acting on Cav3.1 (α1G) with an IC50 of 31.0 μM, Cav3.2 (α1H) with an IC50 of 83.1 μM, and Cav3.3 (α1I) (α1H). T-Type calcium channel inhibitor 2 exhibited cytotoxicity against A549 and HCT-116 cells with IC50s of 5.0 μM and 6.4 μM, respectively.
  • $1,520
10-14 weeks
Size
QTY
Dazostinag disodium
T724822553413-93-5In house
Dazostinag disodium (TAK-676) is a synthetic novel interferon gene (STING) agonist that triggers STING signaling pathway activation and type I interferon activation. Dazostinag disodium (TAK-676) is also a highly effective immune system modulator with complete resolution and lasting memory of T cell immunity and the ability to promote lasting interferon-dependent anti-tumor immune responses.
  • $498 TargetMol
In Stock
Size
QTY
TargetMol | Inhibitor Hot
T-0156
T 0156
T23411L324572-92-1In house
T-0156 is a novel, potent and selective phosphodiesterase type 5 inhibitor that inhibits the hydrolysis of cyclic guanosine monophosphate (cGMP) with low affinity for PDE6, PDE1, PDE2, PDE3 and PDE4.
  • $137
In Stock
Size
QTY
SAK3
SAK-3, SAK 3
T261741256269-87-0In house
SAK3 is a novel modulator of nAChR activity that enhances T-type voltage-gated Ca2+ channel (T-VGCC) activity, and has potentiating effects on both Cav3.1 and Cav3.3 T-type Ca2+ channel currents.SAK3 is neuroprotective against scopolamine-induced cholinergic dysfunction in human neuroblastoma SH-SY5Y cells.SAK3 is used for the study of memory deficits and Alzheimer's disease. SAK3 can be used to study memory deficits and Alzheimer's disease.
  • $129 TargetMol
In Stock
Size
QTY
Oxodipine
T6812390729-41-2In house
Oxodipine, a dihydropyridine-type calcium antagonist, inhibited KCl-induced aortic contraction in rabbits and reduced cardiac force in less potent rat ventricular test-paper contractions. In rat cultured neonatal ventricular myocytes, Oxodipine reduced L-type Ca currents (I) with an IC of 0.24 μM, and against T-type Ca currents (I) with an IC of 0.41 μM. Oxodipine causes constipation in mice and gingival hyperplasia in dogs.
  • $46
In Stock
Size
QTY
Zonisamide
AD 810, CI 912
T026768291-97-4
Zonisamide (AD 810), a sulfonamide anticonvulsant, is approved for use as an adjunctive treatment in adults with partial-onset seizures. It may inhibit a carbonic anhydrase although this is not one of the main mechanisms of action. Zonisamide may act by blocking repetitive firing of voltage-gated sodium channels results in a reduction of T-type calcium channel currents, or by binding allosterically to GABA receptors. This latter action may lower the uptake of the inhibitory neurotransmitter GABA while increasing the uptake of the excitatory neurotransmitter glutamate.
  • $40
In Stock
Size
QTY
Ethosuximide
Zarontin
T072877-67-8
Ethosuximide (Zarontin) is an anticonvulsant, blocks the low voltage-activated T-type calcium channel used in the treatment of absence seizures unaccompanied by other types of seizures.
  • $35
In Stock
Size
QTY
1-Octanol
Octanol
T10024111-87-5
1-Octanol, a saturated fatty alcohol, functions as an inhibitor of T-type calcium channels (T-channels), showing an inhibitory concentration (IC50) of 4 μM for native T-currents[1]. Additionally, 1-Octanol is recognized for its potential as a biofuel, possessing diesel-like properties[2].
  • $39
In Stock
Size
QTY
2-Nitrobenzoic acid
o-Nitrobenzoic acid
T64387552-16-9
2-Nitrobenzoic acid (o-Nitrobenzoic acid) is a antiproliferation agent. 2-Nitrobenzoic acid shows IC50 of 8.3 μM to jurkat cell line expressing T type calcium channel alpha 1H or its splice variant delta 25.
  • $34
In Stock
Size
QTY
Lomerizine dihydrochloride
Terranas, Lomerizine 2HCl, Lomerizine hydrochloride, KB-2796
T6571101477-54-7
Lomerizine dihydrochloride (KB-2796) is an antagonist of L- and T-type voltage-gated calcium channels used to treat migraine.
  • $33
In Stock
Size
QTY
Benzoylmesaconine
Mesaconine 14-benzoate
T6S188563238-67-5
Benzoylmesaconine (Mesaconine 14-benzoate) is the most abundant component of Wutou decoction, which is widely used in China because of its therapeutic effect on rheumatoid arthritis. Benzoylmesconine has analgesic activity. Benzoylmesconine may improve the resistance of T6S-mice (or thermally injured mice) to the infection of HSV-1, through the induction of antagonistic CD4+ T cells against burn-associated type-2 T cells.
  • $33
In Stock
Size
QTY
Mibefradil
Ro 40-5967
TQ0153116644-53-2
Mibefradil is a calcium channel blocker with moderate selectivity for T-type Ca2+ channels (IC50s: 2.7 μM and 18.6 μM for T-type and L-type currents).
  • $2,420
10-14 weeks
Size
QTY
BMS-986449
BMS986449
T204091
BMS-986449 is a CELMoD-type molecular gel that remodels the function of regulatory T cells (Treg) and enhances their anti-tumor immune responses by directing the E3 ubiquitin ligase, Cereblon, to target the degradation of IKZF2 (Helios) and IKZF4 (Eos). BMS-986449 has potential application in the study of advanced solid tumors.
  • $209
6-8 weeks
Size
QTY
TTA-A8
T719901146395-46-1
TTA-A8 is an antagonist of T-type calcium channel.
  • $278
In Stock
Size
QTY
TargetMol | Inhibitor Sale
Fostemsavir Tris
BMS-663068 Tris
T10570864953-39-9
Fostemsavir Tris (BMS-663068 Tris) is the prodrug of BMS-626529,is a oral, safe and effective inhibitor of HIV-1 attachment. It inhibits human immunodeficiency virus type 1 (HIV-1) infection by binding to gp120 and interfering with the attachment of virus to CD4+ T-cells.
  • $52
In Stock
Size
QTY
TargetMol | Inhibitor Sale
JTT 551
T11730776309-04-7
JTT 551 can be used in the research of type 2 diabetes mellitus. JTT 551 is selective a protein tyrosine phosphatase 1B (PTP1B) inhibitor, with Kis of 0.22 μM and 9.3 μM for PTP1B and TCPTP (T-cell protein tyrosine phosphatase), respectively.
  • $1,970
8-10 weeks
Size
QTY
Mibefradil dihydrochloride
Ro 40-5967 (dihydrochloride)
T12032116666-63-8
Mibefradil dihydrochloride (Ro 40-5967 (dihydrochloride)) is an blocker of calcium channel with moderate selectivity for T-type Ca2+ channels (T-type and L-type currents with IC50s of 2.7 μM and 18.6 μM, respectively).
  • $40
In Stock
Size
QTY
ML218 hydrochloride
T120762319922-08-0
ML218 hydrochloride is a selective and orally active T-type Ca2+ channels (Cav3.1, Cav3.2, Cav3.3) inhibitor (Cav3.2 and Cav3.3 with IC50s of 310 nM and 270 nM , respectively).
  • TBD
35 days
Size
QTY
ML218
T12076L1346233-68-8
ML218 is an orally active, selective, potent, and blood-brain barrier-crossing inhibitor of T-type Ca2+ channels (Cav3.1, Cav3.2, Cav3.3) (IC50 for Cav3.2 and Cav3.3 is 310 nM and 270 nM, respectively).ML218 inhibits the burst activity of neurons in the subthalamic nucleus (STN).
  • $54
In Stock
Size
QTY
NNC 55-0396
NNC 55-0396 dihydrochloride
T12238357400-13-6
NNC 55-0396 is a highly selective T-type calcium channel blocker with an IC50 of 6.8 μM, used in studies to prevent human ovarian cancer cell proliferation.
  • $60
In Stock
Size
QTY
TargetMol | Inhibitor Sale
TMPA
T131731258275-73-8
TMPA is a nuclear receptor Nur77 and LKB1 interaction antagonist.
  • $73
In Stock
Size
QTY
TTA-Q6
T13219910484-28-5
TTA-Q6, a selective T-type Ca2+ channel antagonist, exhibits potential antitumor and immunomodulatory activities for treating neurological disorders by inhibiting the uptake of extracellular calcium ions by tumor cells, thereby inducing intracellular calcium deficiency and endoplasmic reticulum (ER) stress.
  • $58
In Stock
Size
QTY
TTA-Q6(isomer)
T13220910484-32-1
TTA-Q6 (isomer) is an isomer of TTA-Q6, which functions as a selective antagonist of the T-type Ca2+ channel.
  • $106
5 days
Size
QTY